These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26109485)

  • 1. Cost of renal replacement: how to help as many as possible while keeping expenses reasonable?
    Vanholder R; Lameire N; Annemans L; Van Biesen W
    Nephrol Dial Transplant; 2016 Aug; 31(8):1251-61. PubMed ID: 26109485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies.
    van der Tol A; Stel VS; Jager KJ; Lameire N; Morton RL; Van Biesen W; Vanholder R
    Nephrol Dial Transplant; 2020 Jun; 35(6):979-986. PubMed ID: 32227227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is renal replacement therapy for all possible in developing countries?
    Aviles-Gomez R; Luquin-Arellano VH; Garcia-Garcia G; Ibarra-Hernandez M; Briseño-Renteria G
    Ethn Dis; 2006; 16(2 Suppl 2):S2-70-2. PubMed ID: 16774015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatment.
    Arrieta J; Rodríguez-Carmona A; Remón C; Pérez-Fontán M; Ortega F; Sánchez Tomero JA; Selgas R
    Nefrologia; 2011; 31(5):505-13. PubMed ID: 21959716
    [No Abstract]   [Full Text] [Related]  

  • 6. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
    Mohnen SM; van Oosten MJM; Los J; Leegte MJH; Jager KJ; Hemmelder MH; Logtenberg SJJ; Stel VS; Hakkaart-van Roijen L; de Wit GA
    PLoS One; 2019; 14(8):e0220800. PubMed ID: 31415578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines.
    Bayani DBS; Almirol BJQ; Uy GDC; Taneo MJS; Danguilan RS; Arakama MI; Lamban AB; de Leon D; Pamugas GEP; Luz AC; Teerawatananon Y
    Nephrology (Carlton); 2021 Feb; 26(2):170-177. PubMed ID: 33207027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeking an optimal renal replacement therapy for the chronic kidney disease epidemic: the case for on-line hemodiafiltration.
    Gatti E; Ronco C
    Contrib Nephrol; 2011; 175():170-185. PubMed ID: 22188699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffs.
    Li B; Cairns JA; Fotheringham J; Tomson CR; Forsythe JL; Watson C; Metcalfe W; Fogarty DG; Draper H; Oniscu GC; Dudley C; Johnson RJ; Roderick P; Leydon G; Bradley JA; Ravanan R
    Nephrol Dial Transplant; 2015 Oct; 30(10):1726-34. PubMed ID: 26071229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost consideration in renal replacement therapy in Kenya.
    Were AJ; McLigeyo SO
    East Afr Med J; 1995 Jan; 72(1):69-71. PubMed ID: 7781562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of renal replacement therapy in Austria.
    Haller M; Gutjahr G; Kramar R; Harnoncourt F; Oberbauer R
    Nephrol Dial Transplant; 2011 Sep; 26(9):2988-95. PubMed ID: 21310740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of various strategies of end-stage renal disease patients' care in France].
    Bongiovanni I; Couillerot-Peyrondet AL; Sambuc C; Dantony E; Elsensohn MH; Sainsaulieu Y; Ecochard R; Couchoud C
    Nephrol Ther; 2016 Apr; 12(2):104-15. PubMed ID: 26915892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of renal replacement therapies: how should we design research on these interventions in Brazil?].
    Sancho LG; Dain S
    Cad Saude Publica; 2008 Jun; 24(6):1279-90. PubMed ID: 18545754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of end stage renal disease treatment.
    de Wit GA; Ramsteijn PG; de Charro FT
    Health Policy; 1998 Jun; 44(3):215-32. PubMed ID: 10182294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
    Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
    Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
    Hidai H
    Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost comparison of kidney transplant versus dialysis in Brazil.
    Silva SB; Caulliraux HM; Araújo CA; Rocha E
    Cad Saude Publica; 2016 Jun; 32(6):. PubMed ID: 27383457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can we achieve global equity in provision of renal replacement therapy?
    White SL; Chadban SJ; Jan S; Chapman JR; Cass A
    Bull World Health Organ; 2008 Mar; 86(3):229-37. PubMed ID: 18368211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Financial incentives and dialysis].
    Keller F; Dress H; Mertz A; Marckmann G
    Med Klin (Munich); 2007 Aug; 102(8):659-64. PubMed ID: 17694285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.